Not Yet Recruiting
Pharmacokinetics, Pharmacodynamics, Safety and Tolerability Evaluation of CTAP101 Extended-release Capsules in Pediatric Participants
NCT07494045
- Conditions
- CKD Stage 3, CKD Stage 4, Endocrine System Diseases, +5 more
- Locations
-
- OPKO Site Kansas City, Missouri, United States
- OPKO Site Columbus, Ohio, United States
- OPKO Site Philadelphia, Pennsylvania, United States
- OPKO Site Greenville, South Carolina, United States